scorecardresearch
Wednesday, July 30, 2025
Topic2-DG

Topic: 2-DG

Mankind Pharma receives DRDO license to manufacture, market Covid drug 2-DG

Drugs Controller General of India (DCGI) had permitted the emergency use of 2-DG on 1 May, as an adjunct treatment for moderate to severe Covid-19 patients.

Dr Reddy’s announces commercial launch of Covid drug 2-DG, to cost Rs 990/sachet

The drug was developed by DRDO in collaboration with Dr Reddy's and granted emergency use approval on 1 May. It will be supplied to major govt and private hospitals across India.

On Camera

No one should have to choose between a roof and two meals. But India’s migrants do, every day

India’s policymakers need to ensure that labourers, and milk and newspaper delivery workers, do not have to sacrifice food just to keep a roof over their heads.

Govt’s earlier FDI limit of 74% in insurance sector has remained underutilised, Parliament told

In the latest budget, the FDI limit was increased to 100 percent, but most foreign companies are not buying such large stakes in the Indian insurance sector.

India’s air defence system foiled 1,000 Pakistani drone attacks on 9 May—Modi tells Parliament

New Delhi: India’s air defence systems intercepted and destroyed 1,000 drones and missiles launched by Pakistan on 9 May during Op Sindoor, Prime Minister...

Modi’s Bharat vs Indira’s India: 11-yr report card of politics, diplomacy, economy, nationalism

As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.